Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

British journal of cancer - 26 Apr 2011

Metcalfe K, Gershman S, Lynch H T, Ghadirian P, Tung N, Kim-Sing C, Olopade O I, Domchek S, McLennan J, Eisen A, Foulkes W D, Rosen B, Sun P, Narod S A

Abstract excerpt

PURPOSE: The objective of this study was to estimate the risk of contralateral breast cancer in BRCA1 and BRCA2 carriers; and measure the extent to which host, family history, and cancer treatment-related factors modify the risk. PATIENTS AND METHODS: Patients were 810 women, with stage I or II breast cancer, for whom a BRCA1 or BRCA2 mutation had been identified in the family. Patients were followed from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Neoplasms, Second Primary

Share to Ovariectomy

Share to Predictive Value of Tests

Share to Risk Assessment

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 21487411
DOI: 10.1038/bjc.2011.120
PMCID: PMC3101934

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.PMID 21487411Read ↗

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.Semantic proximity Read ↗

Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.Semantic proximity Read ↗

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.Semantic proximity Read ↗

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.Semantic proximity Read ↗

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.Semantic proximity Read ↗

Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.Semantic proximity Read ↗

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.Semantic proximity Read ↗

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.